The present invention relates to the use of a photosensitiser which is 5-ALA or a precursor or derivative thereof (e.g. an ALA ester), in the manufacture of a pharmaceutical product for use in the photodynamic treatment or diagnosis of
cancer, an infection associated with
cancer, or in the treatment or diagnosis of a non-cancerous condition, wherein said pharmaceutical product is in the form of a
solid. The invention also relates to
solid pharmaceutical products for use in such methods, e.g. suppositories, pessaries, tablets,
pellets and capsules which comprise 5-ALA or a precursor or derivative thereof (e.g. an ALA ester) and at least one pharmaceutically acceptable carrier or
excipient. Such products are particularly suitable for use in the photodynamic treatment or diagnosis of cancerous or non not cancerous conditions in the lower part of the
gastrointestinal system or in the
female reproductive system, e.g. in the treatment or diagnosis of
colorectal cancer or
cervical cancer.